MedPath

TRAUMACELL - Effects of intravascular administration of mesenchymal stromal cells derived from Wharton’s Jelly of the umbilical cord on systemic immunomodulation and neuroinflammation after traumatic brain injury.

Phase 1/2
Recruiting
Conditions
Severe TBI adult patients
Registration Number
2023-504415-33-00
Lead Sponsor
Assistance Publique Hopitaux De Paris
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing, recruiting
Sex
Not specified
Target Recruitment
88
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Hopital D'Instruction Des Armees Percy

🇫🇷

Clamart, France

Assistance Publique Hopitaux De Paris

🇫🇷

Clichy, France

Hopital D'Instruction Des Armees Percy
🇫🇷Clamart, France
Mathieu BOUTONNET
Site contact
+33141466221
mathieu.boutonnet@intradef.gouv.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.